Transitioning patients from efalizumab to alternative psoriasis therapies: findings from an open-label, multicenter, Phase IIIb study.

Saved in:
Bibliographic Details
Title: Transitioning patients from efalizumab to alternative psoriasis therapies: findings from an open-label, multicenter, Phase IIIb study.
Authors: Menter A; Baylor University Medical Center, Dallas, Texas, USA. amresearch@texasderm.com, Hamilton TK, Toth DP, Leung HM, Wetherill G, Hennessey B, Garovoy M, Kwon P, Pariser DM
Corporate Authors: Efalizumab Study Group
Source: International journal of dermatology [Int J Dermatol] 2007 Jun; Vol. 46 (6), pp. 637-48.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Blackwell Science Country of Publication: England NLM ID: 0243704 Publication Model: Print Cited Medium: Print ISSN: 0011-9059 (Print) Linking ISSN: 00119059 NLM ISO Abbreviation: Int J Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0011-9059
DOI:10.1111/j.1365-4632.2007.03158.x